Search the Appendices of Resolution CM/Res(2018)1
1869 found
INN | ATC Code ▼ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
BEXAROTENE | L01XF03 | NL | Not authorised | VALID | ||||
ALITRETINOIN | L01XF02 | NL | POM | VALID | ||||
FEDRATINIB | L01XE57 | NL | Not authorised | VALID | ||||
AMINOLEVULINIC ACID | L01XD04 | NL | POM | 29-05-2017 | NL/H/2883/001/ | 06-03-2014 | VALID | |
CETUXIMAB | L01XC06 | NL | POM | VALID | ||||
TRASTUZUMAB | L01XC03 | NL | POM | 24-06-2024 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
PROCARBAZINE | L01XB01 | NL | Not subject to prescription | None | VALID | |||
OXALIPLATIN | L01XA03 | NL | Currently not available | NL/H/2063/001/ | 12-11-2014 | VALID | ||
CISPLATIN | L01XA01 | NL | Currently not available | NL/H/2629/001/ | 07-01-2013 | VALID | ||
PERTUZUMAB AND TRASTUZUMAB | L01FY01 | NL | POM | VALID | ||||
ELRANATAMAB | L01FX32 | NL | POM | VALID | ||||
LONCASTUXIMAB TESIRINE | L01FX22 | NL | POM | VALID | ||||
TREMELIMUMAB | L01FX20 | NL | POM | VALID | ||||
AMIVANTAMAB | L01FX18 | NL | POM | VALID | ||||
SACITUZUMAB GOVITECAN | L01FX17 | NL | POM | VALID | ||||
POLATUZUMAB VEDOTIN | L01FX14 | NL | POM | VALID | ||||
TAFASITAMAB | L01FX12 | NL | POM | 07-06-2022 | VALID | |||
OLARATUMAB | L01FX10 | NL | Not authorised | VALID | ||||
MOGAMULIZUMAB | L01FX09 | NL | POM | VALID | ||||
ELOTUZUMAB | L01FX08 | NL | POM | VALID | ||||
BLINATUMOMAB | L01FX07 | NL | POM | VALID | ||||
DINUTUXIMAB BETA | L01FX06 | NL | POM | VALID | ||||
BRENTUXIMAB VEDOTIN | L01FX05 | NL | POM | 27-01-2022 | VALID | |||
IPILIMUMAB | L01FX04 | NL | POM | VALID | ||||
RAMUCIRUMAB | L01FG02 | NL | POM | VALID | ||||
CEMIPLIMAB | L01FF06 | NL | POM | VALID | ||||
ATEZOLIZUMAB | L01FF05 | NL | POM | VALID | ||||
AVELUMAB | L01FF04 | NL | POM | VALID | ||||
DURVALUMAB | L01FF03 | NL | POM | VALID | ||||
PEMBROLIZUMAB | L01FF02 | NL | POM | VALID | ||||
NIVOLUMAB | L01FF01 | NL | POM | VALID | ||||
NECITUMUMAB | L01FE03 | NL | Not authorised | VALID | ||||
PANITUMUMAB | L01FE02 | NL | POM | VALID | ||||
TRASTUZUMAB DERUXTECAN | L01FD04 | NL | POM | VALID | ||||
TRASTUZUMAB EMTANSINE | L01FD03 | NL | POM | VALID | ||||
PERTUZUMAB | L01FD02 | NL | POM | VALID | ||||
TRASTUZUMAB | L01FD01 | NL | POM | VALID | ||||
ISATUXIMAB | L01FC02 | NL | POM | VALID | ||||
DARATUMUMAB | L01FC01 | NL | POM | VALID | ||||
MOXETUMOMAB PASUDOTOX | L01FB02 | NL | POM | VALID | ||||
INOTUZUMAB OZOGAMICIN | L01FB01 | NL | POM | VALID | ||||
OBINUTUZUMAB | L01FA03 | NL | POM | VALID | ||||
OFATUMUMAB | L01FA02 | NL | POM | VALID | ||||
RITUXIMAB | L01FA01 | NL | POM | VALID | ||||
SELPERCATINIB | L01EX22 | NL | POM | VALID | ||||
GILTERITINIB | L01EX13 | NL | POM | VALID | ||||
QUIZARTINIB | L01EX11 | NL | POM | 24-06-2024 | EMEA/H/C/005910 | 06-11-2023 | VALID | |
MIDOSTAURIN | L01EX10 | NL | POM | VALID | ||||
NINTEDANIB | L01EX09 | NL | POM | VALID | ||||
LENVATINIB | L01EX08 | NL | POM | VALID |